UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000010909
Receipt No. R000012766
Official scientific title of the study The effect of melatonin receptor agonist on hemodialysis patients with sleep disturbance
Date of disclosure of the study information 2013/06/08
Last modified on 2017/06/12 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The effect of melatonin receptor agonist on hemodialysis patients with sleep disturbance
Title of the study (Brief title) The effect of melatonin receptor agonist on hemodialysis patients
Region
Japan

Condition
Condition hemodialysis patients with sleep disturbance
Classification by specialty
Nephrology Neurology Psychosomatic Internal Medicine
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine the effect of ramelteon receptor agonist for hemodialysis patients with sleep disturbance
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Interview form and objective assessmennt during hemodialysis
Key secondary outcomes Variability of blood pressure

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria hemodialysis patient with sleep disturbance
Key exclusion criteria Patient who have the contraindication for ramelteon.
Target sample size 40

Research contact person
Name of lead principal investigator Kazuaki Soejima
Organization Saiseikai Kumamoto Hospital
Division name kidney and urology center
Address Chikami 5-3-1,Minami-ku, Kumamoto
TEL 096-351-8000
Email hironobu-inoue@saiseikaikumamoto.jp

Public contact
Name of contact person Hironobu Inoue
Organization Saiseikai Kumamoto Hospital
Division name kidney and urology center
Address Chikami 5-3-1,Minami-ku, Kumamoto
TEL 096-351-8000
Homepage URL
Email hironobu-inoue@saiseikaikumamoto.jp

Sponsor
Institute Saiseikai Kumamoto Hospital
Institute
Department

Funding Source
Organization Saiseikai Kumamoto Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 06 Month 08 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 06 Month 08 Day
Anticipated trial start date
2013 Year 07 Month 01 Day
Last follow-up date
2014 Year 06 Month 30 Day
Date of closure to data entry
2014 Year 06 Month 30 Day
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information none

Management information
Registered date
2013 Year 06 Month 08 Day
Last modified on
2017 Year 06 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012766